Fuji Pharma Co., Ltd. (4554.T)
JPY 1536.0
(0.26%)
JPY 1536.0
(0.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.91 Billion | -658 Million | 5.99 Billion | 5.77 Billion | 7.03 Billion | 3.77 Billion |
| Net Income | 4.39 Billion | 3.72 Billion | 3.37 Billion | 2.91 Billion | 3.96 Billion | 4.47 Billion |
| Depreciation & Amortization | 3.02 Billion | 2.74 Billion | 2.1 Billion | 2.05 Billion | 2.12 Billion | 2.25 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -7.76 Billion | -3.7 Billion | 1.08 Billion | -167 Million | 2.43 Billion | -1.07 Billion |
| Other non-cash items | 2.26 Billion | -3.42 Billion | -564 Million | 962 Million | -1.48 Billion | -1.87 Billion |
| Investing Cash Flow | -5.24 Billion | -11.27 Billion | -2.34 Billion | -2.61 Billion | -12.02 Billion | -1.07 Billion |
| Investments in PPE | -3.89 Billion | -12.42 Billion | -3.89 Billion | -2.61 Billion | -3.28 Billion | -1.63 Billion |
| Acquisitions | 10 Million | 1.38 Billion | 1.67 Billion | 26 Million | 4 Million | 1.28 Billion |
| Investment purchases | - | - | -1.67 Billion | - | -7.78 Billion | - |
| Sales/Maturities of investments | - | - | 189 Million | - | -4 Million | - |
| Other Investing Activities | -1.35 Billion | -231 Million | 1.36 Billion | -27 Million | -954 Million | 557 Million |
| Financing Cash Flow | 1.91 Billion | 5.09 Billion | -5.43 Billion | 450 Million | 7.26 Billion | -2 Billion |
| Debt repayment | -2.74 Billion | -2.14 Billion | -1.75 Billion | -3.14 Billion | -630 Million | -653 Million |
| Dividends payments | -899 Million | -729 Million | -807 Million | -904 Million | -839 Million | -794 Million |
| Common Stock Repurchased | - | - | -9.4 Billion | - | 6.51 Billion | -40 Million |
| Common Stock Issuance | - | - | 11 Million | - | 2.22 Billion | -513 Million |
| Other Financing Activities | 5.55 Billion | 7.96 Billion | 6.52 Billion | 4.49 Billion | -1 Million | -1 Million |
| Accounts receivables | -3.7 Billion | -549 Million | -174 Million | 1.2 Billion | 3.96 Billion | -1.73 Billion |
| Accounts payables | -652 Million | 447 Million | 2.03 Billion | -1.1 Billion | -1.93 Billion | 994 Million |
| Inventory | -3.39 Billion | -3.61 Billion | -1.34 Billion | -23 Million | 581 Million | 235 Million |
| Other working capital | -14 Million | 16 Million | 556 Million | -245 Million | -177 Million | -1.3 Billion |
| Cash at beginning of period | 3.54 Billion | 10.19 Billion | 12.04 Billion | 8.49 Billion | 6.25 Billion | 5.5 Billion |
| Cash at end of period | 2.32 Billion | 3.54 Billion | 10.19 Billion | 12.04 Billion | 8.49 Billion | 6.25 Billion |
| Capital Expenditure | -3.89 Billion | -12.42 Billion | -3.89 Billion | -2.61 Billion | -3.28 Billion | -1.63 Billion |
| Effect of forex changes on cash | 185 Million | 183 Million | -55 Million | -56 Million | -32 Million | 49 Million |
| Net cash flow / Change in cash | -1.22 Billion | -6.65 Billion | -1.84 Billion | 3.54 Billion | 2.24 Billion | 748 Million |
| Free Cash Flow | -1.98 Billion | -13.08 Billion | 2.09 Billion | 3.15 Billion | 3.75 Billion | 2.14 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 653 Million | 1.51 Billion | 2.73 Billion | 4.39 Billion | 1.45 Billion | 210 Million |
| Depreciation & Amortization | - | - | 844 Million | 3.02 Billion | 791 Million | 781 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -7.76 Billion | - | - |
| Other non-cash items | -653 Million | -1.51 Billion | -2.73 Billion | 2.26 Billion | -1.45 Billion | -210 Million |
| Investing Cash Flow | - | - | - | -5.24 Billion | - | - |
| Investments in PPE | - | - | - | -3.89 Billion | - | - |
| Acquisitions | - | - | - | 10 Million | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -1.35 Billion | - | - |
| Financing Cash Flow | - | - | - | 1.91 Billion | - | - |
| Debt repayment | - | - | - | -2.74 Billion | - | - |
| Dividends payments | - | - | - | -899 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | 5.55 Billion | - | - |
| Accounts receivables | - | - | - | -3.7 Billion | - | - |
| Accounts payables | - | - | - | -652 Million | - | - |
| Inventory | - | - | - | -3.39 Billion | - | - |
| Other working capital | - | - | - | -14 Million | - | - |
| Cash at beginning of period | - | - | 2.32 Billion | 3.54 Billion | 3.97 Billion | 5.28 Billion |
| Cash at end of period | - | - | 2.16 Billion | 2.32 Billion | 2.32 Billion | 3.97 Billion |
| Capital Expenditure | - | - | - | -3.89 Billion | - | - |
| Effect of forex changes on cash | - | - | - | 185 Million | - | - |
| Net cash flow / Change in cash | - | - | -163 Million | -1.22 Billion | -1.65 Billion | -1.3 Billion |
| Free Cash Flow | - | - | 1.68 Billion | -1.98 Billion | 1.58 Billion | 1.56 Billion |
ICCH
WLFD
301163
ADUS
017940
BC-PC